pharmaceuticals
publication date
Revenue Cycle
Could This HRSA Pilot Program Signal Future Changes to the 340B Program?
HRSA is piloting a 340B rebate model similar to one that it just fought against. As the agency dips its...
Revenue Cycle
Infographic: Are Drug Companies or Hospitals More Likely to Violate 340B Rules?
In a recent analysis of HRSA data, the American Hospital Association has turned the tables on drug companies and accused...
Technology
Can New DEA Leadership Resolve the Telemedicine Prescription Debate?
A widely panned proposal to regulate virtual prescriptions for controlled drugs isn?t going anywhere. It?s time to bring federal regulators...
Pharma
FDA Layoffs Could Compromise Safety of Medications Made at Foreign Factories, Inspectors Say
Beyond staff cuts, the departures of investigators in recent months have left less experienced people tasked with rooting out dangerous...
Payer
Trump Won't Force Medicaid to Cover GLP-1s for Obesity. A Few States Are Doing It Anyway.
The pricey medications remain out of reach for millions of patients across the country who could benefit from them.
Payer
Mostly False: Trump Exaggerates Speed and Certainty of Prescription Drug Price Reductions
Under a new executive order, prescription drug prices will be reduced 'almost immediately.' ? President Donald Trump, in a May...
Pharma
Pharmacists Stockpile Most Common Drugs on Chance of Targeted Trump Tariffs
Pharmacists find themselves on the front lines of a tariff storm.
Payer
Why Do Americans Pay More for Prescription Drugs?
Drug companies in the U.S. face few restraints on what to charge for their products. A bipartisan bill would penalize...
Pharma
An Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients
FDA inspectors found serious problems at a Glenmark factory in India that manufactured the recalled drugs. Another medication made there...
CFO
Infographic:The CFO Regulatory Guide: 3 Tips for Navigating the Chaos
From tariffs, to Medicaid, to PBMs, here?s what to know.
CFO
Hospitals Get $700M From Drugmakers in Opioid Class-Action Lawsuit
The opioid epidemic has affected hospitals, both clinically and financially, for almost 30 years.
Pharma
Marty Makary, Often Wrong as Pandemic Critic, Is Poised to Lead the FDA He Railed Against
Critics say he exaggerated the harms of the COVID vaccine and undersold the dangers of the virus.